← Open Payments lookup

CHRISTOPHER LEMONS: Open Payments

NPI 1023657236 · ANDOVER, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,862 in 106 payments from 24 companies in 2025. Trend: 2023 $415 · 2024 $1,619 · 2025 $1,862

Food & beverage: $1,862
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP14$306
Lilly USA, LLC10$175
Amgen Inc.12$174
PFIZER INC.14$163
Bayer Healthcare Pharmaceuticals Inc.7$107
Vanda Pharmaceuticals Inc.3$90
Ardelyx, Inc.5$86
Novo Nordisk Inc5$86
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$84
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$71

Products named: FARXIGA, MOUNJARO, Kerendia, AIRSUPRA, OTEZLA, REXULTI, IBSRELA, XIFAXAN.

Industry payments across KS — which companies pay providers there.